In Re: Rivastigmine Patent Litigation Featured Case
Plaintiff: Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd. and Proterra AG
Defendant: Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Sun Pharmaceutical Industries Ltd., Watson Pharmaceuticals Inc., Watson Laboratories Inc., Ranbaxy Inc., Ranbaxy Pharmaceuticals Inc. and Ranbaxy Laboratories Ltd.
Counter Claimant: Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.
Counter Defendant: Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG and Novartis Pharmaceuticals Corporation
Case Number: 1:2005md01661
Filed: February 18, 2005
Court: US District Court for the Southern District of New York
Office: Foley Square Office
County: New York
Presiding Judge: Harold Baer
Presiding Judge: James C. Francis
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: Defendant
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on April 24, 2010. A more recent docket listing may be available from PACER.

Date Filed Document Text
September 25, 2008 Filing 144 STIPULATION OF DISMISSAL: Pursuant to Rules 41(a)(1) and 41(c) of the Federal Rules of Civil Procedure, the Plaintiffs and Defendants Watson Pharmaceuticals, Inc., Watson Laboratories, Inc., and Sun Pharmaceutical Industries Ltd., hereby stipulate and agree that the above actions, including all claims, counterclaims and affirmative defenses, are dismissed without prejudice, and without costs, disbursements or attorneys' fees to any party. (Signed by Judge Harold Baer on 9/25/2008) Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02234-HB, 1:05-cv-02235-HB, 1:05-cv-07820-HB(jfe)
January 18, 2008 Filing 143 NOTICE of of Stipulation of Dismissal. Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Novartis Pharmaceuticals Corporation, Novartis AG. Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:04-cv-06045-HB-JCF(Kallas, Nicholas)
December 3, 2007 Filing 142 NOTICE of Stipulation of Dismissal. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Sun Pharmaceutical Industries Ltd., Watson Pharmaceuticals Inc., Watson Laboratories Inc., Novatis Pharma AG, Novartis International Pharmaceuticals Ltd., Novartis Pharmaceuticals Corp., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc., Novartis International Pharmaceutical, Ltd., Novartis Pharmaceuticals, Sun Pharmaceuticals Ind.. Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02234-HB, 1:05-cv-02235-HB, 1:05-cv-07820-HB(Kallas, Nicholas)
October 30, 2007 Filing 141 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Diego Scambia dated 10/29/07 re: parties request for a 60-day stay of all proceedings in these cases, including all filings and other dates on the case calendar. ENDORSEMENT: "Application granted. So ordered." (Signed by Judge James C. Francis on 10/30/07) (rjm)
October 26, 2007 Filing 140 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Diego Scambia dated 10/25/07 re: Watson and Sun Defendants request for a modest extension of time for two upcoming due dates based upon settlement discussions... that responsive claim papers currently due 10/26/07 be moved to 10/30/07... that plaintiffs' response to defendants' summary judgment motion be moved from 10/31/07 to 11/7/07. ENDORSEMENT: Application granted. So Ordered. (Signed by Magistrate Judge James C. Francis on 10/26/07) (rjm)
October 22, 2007 Filing 139 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Diego Scambia dated 10/19/2007 re: request that responsive claim construction papers be due Friday, 10/26/2007. ENDORSEMENT: Application granted. (Signed by Magistrate Judge James C. Francis on 10/22/2007) (kkc)
October 5, 2007 Filing 138 ENDORSED LETTER addressed to Mag. Judge James C. Francis from Diego Scambia dated 10/5/07 re: The parties request an extension of the due date for responsive claim construction papers until 10/24/07. The parties further request an extension of the due date for pltffs' opposition to defts' motion for summary judgment of non-infringement of claim 3 of U.S. Patent No. 4,848,807, until 10/31/07. ENDORSEMENT: Application granted. (Signed by Judge James C. Francis on 10/5/07) (sn)
September 19, 2007 Filing 134 DECLARATION of Dr. Jay Ellis in Support of Plaintiffs' Opening Brief in Support of Their Proposed Construction of U.S. Patent 4,948,807. Document filed by Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis AG, Novatis Pharma AG, Novartis International Pharmaceuticals Ltd., Novartis Pharmaceuticals Corp., Novartis International Pharmaceutical, Ltd., Novartis Pharmaceuticals. (Attachments: # 1 Exhibit 1-2# 2 Exhibit 3-5)Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:04-cv-06045-HB-JCF, 1:05-cv-02234-HB, 1:05-cv-02235-HB, 1:05-cv-07820-HB(Kallas, Nicholas)
September 12, 2007 Filing 133 ENDORSED LETTER addressed to Magistrate Judge James C. Francis IV from Diego Scambia dated 9/11/07 re: Request on behalf of all parties for an extension from 9/14/07 to 9/19/07 to submit their opening claim construction briefs; and from 10/5/07 to 10/10/07 to submit their responsive claim construction briefs. ENDORSEMENT: Application granted. (Signed by Judge James C. Francis on 9/12/07) (rjm)
August 23, 2007 Filing 131 ENDORSED LETTER addressed to Mag. Judge James C. Francis from Diego Scambia dated 8/9/07 re: The parties request an extension until 8/17/07 to complete their conferral and advise the Court of their views regarding which court(s) should resolve claim construction issues, decide dispositive motions, and try the cases. ENDORSEMENT: Application granted nunc pro tunc. (Signed by Judge James C. Francis on 8/22/07) (sn)
August 23, 2007 Filing 130 ENDORSED LETTER addressed to Mag. Judge James C. Francis from Diego Scambia dated 8/9/07 re: Counsel for pltffs request an extension for pltffs to submit their reply to the counterclaims set forth in "Watson's Amended Answer and Counterclaims to Amended Complaint", until 8/23/07. ENDORSEMENT: Application granted. (Signed by Judge James C. Francis on 8/22/07) (sn)
July 27, 2007 Filing 129 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from James K. Stronski dated 7/26/07 re: Watson's request that Your Honor memo endorse this letter to order that Watson's Amended Answer and Counterclaims to Amended Complaint (1:05-cv-02234, docket entry 26) be permanently placed under seal. ENDORSEMENT: "Application granted." (Signed by Judge James C. Francis on 7/27/07) Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02234-HB(rjm)
July 6, 2007 Filing 128 ENDORSED LETTER addressed to Magistrate Judge James C. Francis IV from James K. Stronski dated 7/3/07 re: Requested entry on behalf of all defendants by Watson defendants for entry of the agreed upon small adjustments to the present case schedule over the next two months. ENDORSEMENT: "Application Granted." Deposition due by 8/31/2007; Discovery due by 8/31/2007; Exchange of reply expert reports and identification or production of documents relied upon by experts due 7/10/07; Simultaneous exchange of list of proposed meanings of claim terms requiring construction due by 8/31/07; Simultaneous submission of opening briefs concerning claim construction due by 9/14/07... and as further set forth in said endorsed letter. (Signed by Judge James C. Francis on 7/6/07) (rjm)
June 4, 2007 Opinion or Order Filing 127 MEMORANDUM & ORDER that for the reasons set forth in this memorandum and order, the defendants' motions to amend are granted. (Signed by Judge James C. Francis on 6/1/07) (rjm)
April 30, 2007 Filing 126 REPLY MEMORANDUM OF LAW in Support MOTION FOR LEAVE TO FILE AN AMENDED ANSWER AND COUNTERCLAIMS. Document filed by Watson Pharmaceuticals Inc., Watson Laboratories Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc.. Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:04-cv-06045-HB-JCF, 1:05-cv-02234-HB, 1:05-cv-02235-HB, 1:05-cv-07820-HB(Stronski, James)
April 19, 2007 Filing 125 REPORT AND RECOMMENDATION... For the reasons set forth in this Report and Recommendation, I recommend that Novartis' motion to dismiss be granted on the condition that the suggested changes are made to its covenant not to sue. Pursuant to 28 U.S.C. 636(b)(1) and Rules 72, 6(a), and 6(e) of the F.R.C.P., the parties shall have ten days from this date to file written objections to this Report and Recommendation. Such objections shall be filed with the Clerk of the Court, with extra copies delivered to the chambers of the Hon. Harold Baer, Room 2230, and to the chambers of the undersigned, Room 1960, 500 Pearl Street, NY NY 10007. Failure to file timely objections will preclude appellate review. (Signed by Judge James C. Francis on 4/19/07) (rjm)
April 19, 2007 Filing 124 MEMORANDUM OF LAW in Opposition to Watson's Motion For Leave To File An Amended Answer and Counterclaims. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis International Pharmaceutical, Ltd., Novartis Pharmaceuticals Corp.. Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02234-HB(Prugo, Filko)
April 6, 2007 Opinion or Order Filing 122 MEMORANDUM AND ORDER... that Novartis' motion to compel production of unredacted copies of documents reviewed by Dr. Wanda Williams prior to her deposition is denied. (Signed by Judge James C. Francis on 4/6/07) (rjm)
March 23, 2007 Filing 120 MEMORANDUM OF LAW in Opposition to Sun Pharmaceutical's Motion For Leave To File Instanter A Surreply To Plaintiffs' Motion To Dismiss With Prejudice Their Action Against Sun For Infringement of U.S. Patent No. 5,602,176. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novatis Pharma AG, Novartis International Pharmaceuticals Ltd., Novartis Pharmaceuticals Corp.. Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02235-HB(Prugo, Filko)
March 22, 2007 Filing 119 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from James K. Stronski dated 3/21/07 re: Defts. have worked hard to complete fact discovery, but the March 23 date for the exchange of expert reports is impossible for them. Accordingly, Watson & Sun plead for relief from the extreme prejudice that will result from the current schedule and propose the following schedule through expert discovery: 3/16/07 (fact discovery deemed complete); 3/30/07 (exchange contention interrogatories answers on '807); 4/27/07 (exchange of expert reports and identification or production of documents relied upon by experts); 6/4/07 (exchange of rebuttal reports and identification or production of documents relied upon by experts); 6/18/07 (exchange of reply reports and identification or production of documents relied upon by experts); and, 6/22/07 - 7/22/07 (period to take expert depositions). Under defts' proposal, the end date for expert discovery remains the same. Defts are available to appear in person or by telephone, in advance of 3/23/07, to address any questions that the Court may have on this emergency application. "The Schedule set forth above is adopted as modified." (Signed by Judge James C. Francis on 3/23/07) (rjm)
March 19, 2007 Filing 117 DECLARATION of Simon A. Fitzpatrick in Support re: (110 in 1:05-md-01661-HB-JCF, 16 in 1:05-cv-02235-HB) MOTION to Dismiss with Prejudice Their Action Against Sun for Infringement of US Patent No 5,602,176., (109 in 1:05-md-01661-HB-JCF, 22 in 1:05-cv-02234-HB) MOTION to Dismiss with Prejudice their Claim Agaisnt Watson for Infringement of US Patent No. 5,602,176 and Dismiss without Prejudice Watson's Counterclaims Concerning that Patent.. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novatis Pharma AG, Novartis International Pharmaceuticals Ltd., Novartis Pharmaceuticals Corp., Novartis International Pharmaceutical, Ltd.. (Attachments: # 1 Exhibit 1 and 2# 2 Exhibit 3 and 4)Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02234-HB, 1:05-cv-02235-HB(Prugo, Filko)
March 15, 2007 Minute Entry for proceedings held before Magistrate Judge James C. Francis : Discovery Telephone Conference held on 3/15/2007, 5:30pm. Duration: 15 min. (rjm)
March 12, 2007 Filing 115 ENDORSED LETTER addressed to Magistrate Judge James C. Francis IV from Barry S. White dated 3/2/07 re: "Absent an agreement that shortens the current timeline, counsel shall continue to abide by the schedule currently in place." (Signed by Judge James C. Francis on 3/12/07) (rjm)
March 1, 2007 Filing 111 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from James K. Stronski dated 2/28/2007; counsel writes to proposed the following briefing schedule on plaintiffs' motions to dismiss the '176 patent: defendants' responses due 3/2/2007; plaintiffs' replies due 3/16/2007. ENDORSEMENT: Application granted. (Signed by Magistrate Judge James C. Francis on 3/1/2007) (kkc)
February 28, 2007 Filing 110 MOTION to Dismiss with Prejudice Their Action Against Sun for Infringement of US Patent No 5,602,176. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novatis Pharma AG, Novartis International Pharmaceuticals Ltd., Novartis Pharmaceuticals Corp..Motions referred to James C. Francis. (Attachments: # 1 Text of Proposed Order)Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02235-HB(Prugo, Filko)
February 28, 2007 Filing 109 MOTION to Dismiss with Prejudice their Claim Agaisnt Watson for Infringement of US Patent No. 5,602,176 and Dismiss without Prejudice Watson's Counterclaims Concerning that Patent. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis International Pharmaceutical, Ltd., Novartis Pharmaceuticals Corp..Motions referred to James C. Francis. (Attachments: # 1 Text of Proposed Order)Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02234-HB(Prugo, Filko)
February 28, 2007 ***NOTE TO ATTORNEY TO RE-FILE DOCUMENT - DOCUMENT TYPE ERROR. Note to Attorney F. Prugo to RE-FILE Document 106 Notice (Other). Use the document type Motion to Dismiss found under the document list Motions. (gf)
February 28, 2007 ***NOTE TO ATTORNEY TO RE-FILE DOCUMENT - DOCUMENT TYPE ERROR. Note to Attorney F. Prugo to RE-FILE Document 103 Notice (Other. Use the document type Motion to Dismiss found under the document list Motions. (gf)
February 22, 2007 Filing 114 LETTER addressed to Magistrate Judge James C. Francis IV from James K. Stronski dated 2/9/07 re: three related discovery matters: (i) Ptffs' refusal to produce the agreement (and related documents) in this case between Ptffs. and Deft. Dr. Reddy's underlying the stay of all claims by and against Dr. Reddy's; (ii) Ptffs' refusal to produce the translations of the privileged documents that were submitted to the Court for in camera review and ordered to be produced no later than 12/15/06; and (iii) Ptffs' failure thus far to schedule the depositions of Messrs. Ross and Wyman and Dr. Enz, which were noticed following the production of documents previously withheld as privileged... We request the opportunity to appear, in person or by telephone, at the Court's earliest convenience to address these matters. Document filed by Watson Pharmaceuticals Inc., Watson Laboratories Inc. Attached is letter addressed to Magistrate Judge James C. Francis IV from Diego Scambia dated 2/15/07 Re: plaintiffs request that defendants' motion to compel be denied or, if granted, be made subject to appropriate conditions... with Exhibits 1 through 7 attached.(rjm)
February 21, 2007 Opinion or Order Filing 108 ORDER... that Watson and Sun's request for an order compelling production of all documents relating to the agreement between plaintiffs and defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. is denied... Watson and Sun's application for an order compelling plaintiffs to produce their translations of foreign language documents produced in discovery is granted... Plaintiffs' request for a further condition that the translations may not be used with any witness or expert in deposition or at trial is denied... and as further set forth in said order. (Signed by Judge James C. Francis on 2/21/07) (rjm)
February 9, 2007 Filing 106 FILING ERROR - WRONG DOCUMENT TYPE SELECTED FROM MENU - NOTICE of Motion to Dismiss with Prejudice Their Claim Against Watson for Infringement of US Patent 5,602,176 and Dismiss without Prejudice Watson's Counterclaims Concerning that Patent. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novartis International Pharmaceutical, Ltd., Novartis Pharmaceuticals Corp.. (Attachments: # 1 Text of Proposed Order)Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02234-HB(Prugo, Filko) Modified on 2/28/2007 (gf).
February 8, 2007 Opinion or Order Filing 105 ORDER REFERRING CASE TO MAGISTRATE JUDGE. Order that case be referred to the Clerk of Court for assignment to a Magistrate Judge for Dispositive Motions Novartis' Motions for Voluntary Dismissal. Referred to Magistrate Judge James C. Francis. (Signed by Judge Harold Baer on 2/7/07) (rjm)
February 2, 2007 Filing 103 FILING ERROR - WRONG DOCUMENT TYPE SELECTED FROM MENU - NOTICE of of Plaintiffs' Motion to Dismiss With Prejudice Their Action Against Sun for Infringement of US Patent 5,602,176. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation, Novatis Pharma AG, Novartis International Pharmaceuticals Ltd., Novartis Pharmaceuticals Corp., Novartis Pharmaceuticals. (Attachments: # 1 Text of Proposed Order)Filed In Associated Cases: 1:05-md-01661-HB-JCF, 1:05-cv-02235-HB, 1:05-cv-07820-HB(Prugo, Filko) Modified on 2/28/2007 (gf).
January 3, 2007 Opinion or Order Filing 102 STIPULATION AND ORDER... It is hereby stipulated and agreed by and between the undersigned counsel for Plaintiffs and Defendants that the following schedule shall govern the remainder of the proceedings in this Court. Expert Depositions due by 7/27/2007. Fact Discovery due by 2/9/2007. Dispositive Motions due by 11/2/2007. Replies to Dispositive Motions due by 12/14/2007. Responses to dispositive motions due by 11/30/2007. Service to Responses to Contention Interrogatories due 2/23/07. Identification of opening experts on which parties will rely for opening expert reports due 3/2/07. Submission of opening expert reports due 3/23/07. Production/identification of expert documents relating to opening expert reports due 3/30/07. Submission of rebuttal expert reports due 5/4/07. Production/identification of expert documents relating to rebuttal expert reports due 5/25/07. Submission of reply expert reports due 5/25/07. Production/identification of expert documents relating to reply expert reports due 6/1/07. Close of expert discovery due 7/27/07. Simultaneous exchange of list of proposed meanings of claim terms requiring construction due 8/10/07. Simultaneous Submission of Opening briefs concerning claim construction due 9/7/07. Simultaneous Submission of Response briefs concerning claim construction due 10/5/07. (Signed by Judge James C. Francis on 12/28/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, )
December 20, 2006 Opinion or Order Filing 101 MEMORANDUM AND ORDER... that Novartis' assertions of privilege with respect to Documents Nos. 207 and 209 are upheld. (Signed by Magistrate Judge James C. Francis on 12/20/06) (rjm, )
December 5, 2006 Opinion or Order Filing 78 ORDER... that by 12/11/06, Novartis shall provide any supplemental submissions regarding documents 207 and 209. Defts. shall submit answering papers by 12/13/06, and Novartis shall reply by 12/15/06. By 12/15/06, Novartis shall produce all documents that were the subject of the Court's order on the "Swiss motion." December 15, 2006 shall therefore serve as the anchor date for the deadlines set forth in the Stipulation and Order dated 11/28/06. (Signed by Judge James C. Francis on 12/5/06) (rjm, )
December 4, 2006 Minute Entry for proceedings held before Mag. Judge James C. Francis : Telephone Conference held on 12/4/2006. (rjm, )
November 27, 2006 Opinion or Order Filing 77 STIPULATION AND ORDER... regarding the schedule that shall govern the remainder of the proceedings in this Court... and as further set forth in said stipulation and order. (Signed by Judge James C. Francis on 11/22/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, )
November 22, 2006 Opinion or Order Filing 76 OPINION & ORDER; plaintiff's motion to reconsider that portion of Magistrate Francis' decision is Denied. Magistrate Francis' ruling regarding documents 207 and 209 is Remanded to his Court for proceedings consistent with this Opinion. The Clerk of the Court is instructed to close this motion and remove it from my docket. (Signed by Judge Harold Baer on 11/22/2006) (kkc, )
October 30, 2006 Minute Entry for proceedings held before Magistrate Judge James C. Francis: Telephone Conference held on 10/30/2006. (kkc, )
October 30, 2006 Opinion or Order Filing 75 ORDER; David M. Conca is permitted to withdraw as counsel in these actions and the clerk is directed to note such withdrawal. (Signed by Judge Harold Baer on 10/27/06) (sn)
September 29, 2006 Opinion or Order Filing 74 ORDER... Regarding the procedures to be followed that shall govern the handling of the "Category Four" documents. (Signed by Judge James C. Francis on 9/29/06) (rjm, )
August 31, 2006 Opinion or Order Filing 70 STIPULATION AND ORDER regarding the procedures to be followed that shall govern the handling of Privileged Documents. This Document relates to All Actions. (Signed by Judge James C. Francis on 8/31/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, )
August 29, 2006 Filing 67 ENDORSED LETTER addressed to Judge Harold Baer from Diego Scambia dated 8/18/06 re: Parties' joint request of briefing schedule, which would extend by about one week the due date for submission of any motion/objection papers, answering papers, and reply papers. "The extension is granted." Motion/Objection papers due by 8/29/06. Replies due by 9/20/2006. Responses due by 9/12/2006 (Signed by Judge Harold Baer on 8/29/06) (rjm, )
August 29, 2006 Filing 66 ENDORSED LETTER addressed to Magistrate Judge James C. Francis IV from Diego Scambia dated 8/17/06 re: "Application granted re the category four documents. The issue of scheduling the briefing of objections to my memorandum and order has appropriately been directed to Judge Baer." (Signed by Judge James C. Francis on 8/28/06) (rjm, )
August 29, 2006 Opinion or Order Filing 65 ORDER. Defendant Sun Pharmaceutical Industries, Ltd. having moved to amend its answer in 05cv7820 (HB) and 05cv2235 (HB), and plaintiff having indicated that they do not oppose the motion, it is hereby ordered that Sun is granted leave to file amended answers in the form attached as Exhibits A and B to Sun's motion. (Signed by Judge James C. Francis on 8/29/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, )
August 11, 2006 Filing 63 NOTICE OF APPEARANCE by Haejin Sarah Park on behalf of Watson Pharmaceuticals Inc., Watson Laboratories Inc. (Park, Haejin)
August 10, 2006 Filing 62 ENDORSED LETTER addressed to Mag. Judge James C. Francis from James K. Stronski dated 8/9/06 re: Request that the Court add Mr. White's name above mine (James K. Stronski) on this order. Also request that his name so appear on any subsequent Orders or opinions. "Unfortunately, the order has been filed and entered in the electronic database. I apologize for the oversight. Mr. White's name will appear on future orders." (Signed by Magistrate Judge James C. Francis on 8/10/06) (rjm, )
August 8, 2006 Opinion or Order Filing 61 MEMORANDUM AND ORDER... that the pending discovery motions are resolved as set forth above and in the attached Appendix. The parties are directed to file their submissions regarding the category four documents within two weeks of this Order... and as further set forth regarding the procedures to be followed that shall govern the handling of document production. (Signed by Judge James C. Francis on 8/8/06) (rjm, ).
May 31, 2006 Opinion or Order Filing 60 STIPULATION AND ORDER. It is hereby stipulated and agreed, between Novartis and DRL, through their undersigned attorneys, that This DRL Action is stayed in its entirety; DRL stipulates that if the '807 patent is held enforceable, and either claim 3 or 4 of the '807 patent is held valid, the valid claim(s) would be infringed by its rivastigmine tartrate ANDA product, and that if the '176 patent is held enforceable, and any claims 1, 2, 3 or 5 of the '176 patent is held valid, the valid claims would be infringed by its rivastigmine tartrate ANDA product... and as further set forth in said stipulation and order. (Signed by Judge James C. Francis on 5/31/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF(rjm, )
March 20, 2006 Filing 59 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Diego Scambia dated 3/20/2006; granting counsel's application to submit their privilege reply papers by 3/24/2006. (Signed by Magistrate Judge James C. Francis on 3/20/2006) (kkc, )
March 3, 2006 Filing 58 ENDORSED LETTER addressed to Magistrate Judge James C. Francis IV from Diego Scambia dated 3/2/06 re: Granted request for plaintiffs to submit their privilege reply brief by March 22, 2006. (Signed by Judge James C. Francis on 3/3/06) (rjm, )
February 27, 2006 Opinion or Order Filing 57 STIPULATION AND ORDER that the collective "Plaintiffs" and "Sun" through their respective counsel, and in order to narrow the issues of pretrial discovery and trial and to conserve judicial resources, stipulate as follows: Sun stipulates it infringes claims 1, 2, and 3 of the '176 patent, should the Court find these claims valid and enforceable. Sun reserves all challenges to the validity and enforceability of the claims of the '176 patent. This stipulation is no admission of liability and is made to simplify this litigation. Plaintiffs stipulate & agree to forgo taking the depositions of Messrs. Shivramchandra, Doshi, and Rajamannar, subject to there being a substantial need to take those depositions in light of the production of any additional documents. Sun stipulates that Messrs. Doshi, Shivramchandra and Rajamannar will not appear as witnesses at trial or otherwise, unless their depositions are taken... and as further set forth in said stipulation & order. (Signed by Judge James C. Francis on 2/24/06) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-07820-HB(rjm, )
February 15, 2006 Filing 56 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Maurice N. Ross dated 2/14/06 re: Granted request that Defendants' joint response to plaintiffs collective submissions in support of their claims of privilege would be submitted on 2/22/06 (a one week extension from the present 2/15/06 deadline). (Signed by Judge James C. Francis on 2/15/06) (rjm, )
February 8, 2006 Filing 55 ENDORSED LETTER addressed to Mag. Judge James C. Francis from Diego Scambia dated 2/7/06 re: Granted request by plaintiffs for a two-week extension from 2/9/06 to 2/23/06 for plaintiffs either to advise the Court that the dispute raised by Sun's 1/17/06 letter motion is resolved and submit a stipulation for approval, or submit an opposition to Sun's motion. (Signed by Judge James C. Francis on 2/8/06) (rjm, )
January 20, 2006 Filing 52 ENDORSED LETTER addressed to Magistrate Judge Francis from Diego Scambia dated 1/19/06 re: Granting counsel for pltffs' request for an extension of time to submit any response to Sun's 1/17/06 letter motion for a protective order, to 2/9/06. (Signed by Judge James C. Francis on 1/20/06) (sn)
January 12, 2006 Filing 51 LETTER addressed to Magistrate judge James C. Francis from Diego Scambia dated 1/11/2006, re: response to defendants' 1/10/2006 letter. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation.(kkc, )
January 12, 2006 Filing 50 LETTER addressed to Magistrate Judge James C. Francis from Maurice N. Ross dated 1/10/2006, re: response to plaintiffs' 1/9/2006 letter requesting clarification of the Court's 1/4/2006 Order. Document filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.(kkc, )
January 12, 2006 Filing 49 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Diego Scambia dated 1/9/2006; counsel writes to request clarification concerning providing information categorically, and not on a document-by-document basis. ENDORSEMENT: provision of this information on a categorical basis for foreign prosecution files is appropriate. (Signed by Magistrate Judge James C. Francis on 1/12/2006) (kkc, )
January 5, 2006 Opinion or Order Filing 48 MEMORANDUM AND ORDER... By 1/20/06, plaintiffs shall supplement their answers to defendants' interrogatories concerning the plaintiffs, claims of privilege by: providing the relevant qualification and the date of such qualifying event for each legal professional, and providing interrogatory answers with respect to all other documents withheld on the basis of privilege that include information equivalent to that provided for documents subject to the "Swiss motion." In all other respects, the plaintiffs' interrogatory answers are sufficient and need not be supplemented. The defendants shall advise the Court when and how they intend to renew the "Swiss motion" in light of the plaintiffs' interrogatory answers. (Signed by Magistrate Judge James C. Francis on 1/4/05) (rjm, )
January 5, 2006 Opinion or Order Filing 47 MEMORANDUM AND ORDER... that defendants' motion to compel production of documents created or received by Mr. Borovian is denied. (Signed by Magistrate Judge James C. Francis on 1/5/05). (rjm, )
November 23, 2005 Opinion or Order Filing 46 OPINION & ORDER that Magistrate Francis' order dated 9/22/05 is affirmed. The Clerk of the Court is instructed to remove this motion from my docket. (Signed by Judge Harold Baer on 11/22/05) (rjm, )
November 21, 2005 Opinion or Order Filing 45 EXCIPIENT SAMPLE STIPULATION AND ORDER that Reddy agrees that in each of the rivastigmine capsule products that are the subject of its ANDA, the excipients will not in any way affect testing results concerning the amount of (S)-N-ethyl-N-methyl-3-(1-(dimethylamino)ethyl)-phenyl carbamate present in those products... and as further set forth in said order. (Signed by Judge James C. Francis on 11/21/05) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF(rjm, )
November 21, 2005 Opinion or Order Filing 44 ORDER that the Reddy Defts. having submitted a letter motion seeking an order compelling the plaintiffs to produce certain documents withheld on grounds of privilege & requiring ptffs. to amend their privilege log to provide more specific information, it is ordered that further amendment of the privilege log would be insufficient & shall not be required. By 12/9/05, the ptffs. shall produce for my in camera inspection all documents identified by the Reddy Defendants in the 9/28/05 letter of Maurice N. Ross... By 12/23/05, defts. shall submit a letter responding to ptffs' individual & categorical claims of privilege with respect to the disputed documents. Ptffs shall submit any reply by 12/30/05. (Signed by Magistrate Judge James C. Francis on 11/21/05) (rjm, )
October 6, 2005 Minute Entry for proceedings on contested issueheld before Judge James C. Francis : Telephone Conference (Discovery Dispute) held on 10/6/2005, 10:30am. (rjm, )
October 6, 2005 Filing 40 ENDORSED LETTER addressed to Mag. Judge James C. Francis IV from Maurice N. Ross dated 10/5/05 re: The requested reply date is adopted regardless of whether the common interest ruling is appealed. (Signed by Judge James C. Francis on 10/5/05) (rjm, )
October 6, 2005 Filing 39 ENDORSED LETTER addressed to Magistrate Judge James C. Francis IV from Diego Scambia dated 10/5/05 re: GRANTED request for a 10 day extension of time - from October 11 to October 21 - for plaintiffs to submit a response to the Reddy defts' September 28 motion to compel. (Signed by Judge James C. Francis on 10/5/05) (rjm, )
October 6, 2005 Set/Reset Deadlines: Responses due by 10/21/2005 (rjm, )
September 30, 2005 Minute Entry for proceedings on contested issue held before Magistrate Judge James C. Francis : Telephone Conference (Pretrial)held on 9/30/2005, 1:00pm. (rjm, ) Modified on 11/21/2005 (rjm, ).
September 30, 2005 Opinion or Order Filing 38 ORDER A pretrial conference having been held by telephone on 9/30/05, it is ordered that the discovery schedule set forth in the Order dated 5/9/05 is modified: Expert Deposition due by 4/3/2006. Fact Discovery due by 1/13/2006. Submission of opening expert reports due 1/27/06, rebuttal expert reports due 2/24/06, reply expert reports due 3/10/06. Completion of expert discovery due 5/12/06. Motions due by 6/16/2006. Replies due by 7/28/2006. Responses due by 7/14/2006 (Signed by Judge James C. Francis on 9/30/05) (rjm, )
September 22, 2005 Opinion or Order Filing 37 MEMORANDUM AND ORDER that defendants' motion to compel production of communications between the inventors of Rivastigmine or their representatives and Novartis is granted. Their motion to compel production of documents reflecting communications between Novartis and its in-house counsel or Swiss or other European patent agents is denied without prejudice to being renewed in connection with specifically identified documents. (Signed by Judge James C. Francis on 9/22/05) (rjm, ) Additional attachment(s) added on 9/28/2005 (tr, ).
September 7, 2005 Filing 35 CERTIFIED TRUE COPY OF CONDITIONAL MDL TRANSFER IN ORDER FROM THE MDL PANEL (CTO-1)... that pursuant to 28 U.S.C. 1407, the actions listed on the attached schedule A and pending in the Northern District of Illinois, C.A. No. 1:05-4004, and the same hereby are, transferred to the Southern District of New York, with the consent of that court, assigned to the Honorable Judge Harold Baer, Jr., for coordinated or consolidated pretrial proceedings with the actions pending in that district and listed on Schedule A. (Signed by MDL Panel on 8/11/05) (rjm, )
August 17, 2005 Filing 34 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Diego Scambia dated 8/11/05 re: Granting counsel for pltffs' request for leave to file a surreply brief with respect to the Swiss motion, and a supplemental declaration on Swiss law, to be submitted 3 business days from entry of the Order granting leave to make their submission. (Signed by Judge James C. Francis on 8/17/05) (sn)
July 26, 2005 Filing 33 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Maurice N. Ross dated 7/25/2005; counsel writes to propose a briefing schedule on the motions to compel. ENDORSEMENT: Plaintiffs shall answer both motions by 8/3/2005, and defendants shall reply by 8/5/2005. (Signed by Magistrate Judge James C. Francis on 7/26/2005) (kkc, )
July 25, 2005 CIVIL MEMORANDUM TO DOCKET CLERK for proceedings held before Magistrate Judge James C. Francis : Discovery Telephone Conference (contested issue) held on 7/21/2005, 3:00pm. (rjm, )
July 25, 2005 Opinion or Order Filing 32 ORDER that for purposes of this litigation, it shall be presumed that the plaintiffs on one hand and the defendants, collectively, on the other shall be entitled to take no more than 20 depositions each and that no deposition shall last more than two days. These limitations may be modified by agreement of the parties or for good cause shown. For the purposes of scheduling deposition, however, counsel shall utilize the time estimate provided by the party noticing the deposition. It shall be presumed that, in the absence of a medical condition that dictates otherwise, the deposition of any witness witrhin the control of a party shall be conducted in New York. (Signed by Judge James C. Francis on 7/25/05) (rjm, )
July 1, 2005 Opinion or Order Filing 31 ORDER that defendants' application for an order directing plaintiffs to produce Albert Enz or another witness to testify as to all relationships, dealings, communications, contacts, or agreements between the plaintiffs and the Israeli entities and to refrain from objecting to the disclosure of communications between plaintiffs or their counsel... is DENIED. Martin Lutz & Edward J. Wilusz were adequate witnesses given the limited scope of the preliminary depositions. Whether privilege, work product and scope of discovery objections were properly asserted need not be determined at this time since the plaintiffs' solicitation of documentsfrom the Israeli entities after the initiation of this action has little probative value on the issue of the relation between the plaintiffs and those entities. (Signed by Judge James C. Francis on 7/1/05) (rjm, )
June 13, 2005 Filing 29 REPLY to Watson's Answer and Counterclaims to the Amended Complaint. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:05-cv-02234-HB(Conca, David)
June 9, 2005 Filing 28 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Gregory B. Sephton dated 6/8/05 re: GRANTING plaintiffs request for a brief extension until Friday, 6/10/05, for plaintiffs to determine whether to object to defendant Watson's designation of a proposed expert witness, Dr. Rosenberry. (Signed by Judge James C. Francis on 6/8/05) (rjm, )
June 1, 2005 Opinion or Order Filing 27 ORDER pursuant to pretrial conference held by telephone on 5/31/05 regarding the rules to be followed for discovery, production of documents, and depositions. (Signed by Judge James C. Francis on 6/1/05) (rjm, )
May 31, 2005 Filing 26 Civil Memo to the Docket Clerk; Minute Entry for proceedings held before Judge James C. Francis : Telephone Conference held on 5/31/2005, 2:30pm. for 30 minutes on contested issue. (rjm, )
May 31, 2005 Filing 24 ANSWER to Counterclaim. Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(Conca, David)
May 26, 2005 Filing 23 ENDORSED LETTER addressed to Magistrate Judge James C. Francis IV from Brooks R. Bruneau dated 5/25/05 re: Counsel for plaintiff Novartis, Diego Scambia, has consented to Ranbaxy's request for additional 15 days to file & serve its Answer from 5/25/05 to 6/9/05. (Signed by Judge James C. Francis on 5/26/05) (rjm, )
May 26, 2005 Set Answer Due Date purs. to 23 Endorsed Letter, as to Ranbaxy Inc. answer due on 6/9/2005; Ranbaxy Pharmaceuticals Inc. answer due on 6/9/2005; Ranbaxy Laboratories Ltd. answer due on 6/9/2005. (rjm, )
May 23, 2005 Filing 22 ANSWER to Amended Complaint with JURY DEMAND. Document filed by Sun Pharmaceutical Industries Ltd.. Related document: 15 Amended Complaint, filed by Novartis AG,, Novartis Pharmaceuticals Corporation,, Novartis Pharma AG,, Novartis International Pharmaceutical Ltd.,.(Poullaos, Ivan)
May 19, 2005 Filing 21 AMENDED ANSWER to., COUNTERCLAIM against all plaintiffs. Document filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-03160-HB(Ross, Maurice)
May 19, 2005 ***NOTE TO ATTORNEY TO RE-FILE DOCUMENT - DEFICIENT DOCKET ENTRY ERROR. Note to Attorney Maurice Ross to RE-FILE Document 19 Amended Answer to Complaints, Counterclaim. ERROR(S): Attorney selected ALL DEFENDANTS as the parties to whom the attorney was filing the Counterclaim against. (kkc, )
May 18, 2005 Filing 19 FILING ERROR - DEFICIENT DOCKET ENTRY (WRONG COUNTERCLAIM DEFENDANTS SELECTED) - AMENDED ANSWER to., COUNTERCLAIM against all defendants. Document filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-03160-HB(Ross, Maurice) Modified on 5/20/2005 (kkc, ).
May 17, 2005 Opinion or Order Filing 20 ORDER on attached Notice of Motion to Admit Derek J. Sarafa and Ivan M. Poullaos as attorneys pro hac vice on behalf of Deft. Sun Pharmaceutical Industries, Ltd. (Signed by Judge Harold Baer on 5/17/05) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:05-cv-02235-HB(rjm, )
May 16, 2005 Filing 18 CERTIFICATE OF SERVICE of Amended Answer and Counterclaims served on Novartis Pharmaceuticals Corp, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceuticals, Proterra AG on May 12, 2005. Service was made by Mail. Document filed by Dr. Reddy's Laboratories, Inc.. Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF(Ross, Maurice)
May 13, 2005 Filing 17 ENDORSED LETTER addressed to Magistrate Judge James C. Francis from Ivan M. Poullaos dated 5/12/2005; granting counsel's application to request that the Court insert the name of Dr. Ratnesh Shrivastava as Sun Pharmaceutical Industries, Ltd.'s second designee permitted to view Highly Confidential and Confidential documents under the Protective Order. (Signed by Magistrate Judge James C. Francis on 5/12/2005) (kkc, )
May 12, 2005 Filing 13 ANSWER to Complaint., COUNTERCLAIM against all plaintiffs. Document filed by Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B)(Ross, Maurice)
May 10, 2005 Filing 16 AMENDED COMPLAINT (this document relates to 04cv6045) against Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(kkc, )
May 10, 2005 Filing 15 AMENDED COMPLAINT (this document relates to 05cv2235) against Sun Pharmaceutical Industries Ltd.Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(kkc, )
May 10, 2005 Filing 14 AMENDED COMPLAINT (this document relates to 05cv2234) against Watson Pharmaceuticals Inc., Watson Laboratories Inc.Document filed by Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., Proterra AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certificate of Service)(kkc, )
May 10, 2005 Case Designated ECF. (kkc, )
May 10, 2005 Opinion or Order Filing 12 PROTECTIVE ORDER; regarding procedures to be followed that shall govern the handling of Confidential Materials. (Signed by Magistrate Judge James C. Francis on 5/9/2005) Copies Mailed by Chambers.(kkc, )
May 10, 2005 Opinion or Order Filing 11 CASE MANAGEMENT ORDER NO. 1 (this document relates to all actions); 1. All attorneys who have been admitted to this Court, either for all purposes or pro hac vice for purposes of this case, shall complete and file a CM/ECF attorney registration form. Forms can be found on the court's website at www.nysd.uscourts.gov.2. All attorneys who wish to be admitted for purposes of this case shall send a motion to be admitted pro hac vice to John Sacco at the United States District Court for the Southern District of New York, 500 Pearl Street, Room 249, New York, NY 10007. In addition to the documentation required by the Local Rules for the Southern and Eastern Districts of New York, Civil Rule 1.3, attorneys wishing to appear pro hac vice must also include with their motion a check for $25.00 payable to the Clerk of the Court and a completed CM/ECF attorney registration form. 3. As of May 9, 2005, all documents filed in the MDL case and the underlying civil cases shall be filed electronically on the court's ECF system via the Internet at ecf.nysd.uscourts.gov4. Amended complaints and supplemental pleadings shall provide a list of the additional parties and indicate the action or actions to which they are being added. Similarly, a filing removing parties shall indicate the parties being removed and the action or actions from which they are being removed. A filing which adds a party or parties who has not been named in any of the consolidated actions shall provide a separate listing of such parties, indicating that they have not yet been named. (Signed by Magistrate Judge James C. Francis on 5/9/2005) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:04-cv-06045-HB-JCF,1:05-cv-02234-HB,1:05-cv-02235-HB,1:05-cv-03160-HB(kkc, )
May 10, 2005 Opinion or Order Filing 10 ORDER; regarding pretrial conference held on 5/5/2005; completion of document production - 6/24/2005; fact depositions commence - 7/11/2005; exchange of privilege logs - 6/30/2005; fact discovery completed - 10/14/2005; submission of opening expert reports - 10/28/2005; submission of rebuttal expert reports - 12/5/2005; submission of reply expert reports - 12/19/2005; expert depositions 1/9/2006 - 2/24/2006; completion of expert discovery - 2/24/2006; submission of dispositive motions - 4/24/2006; submission of answering papers - 5/26/2006; submission of reply papers - 6/15/2006; the time for the Ranbaxy Defendant to answer or move with respect to the complaint is extended to 5/25/2005. All other rulings are set forth in this Order. (Signed by Magistrate Judge James C. Francis on 5/9/2005) Copies Mailed by Chambers.(kkc, )
May 5, 2005 Minute Entry for proceedings held before Magistrate Judge James C. Francis: Pretrial Conference held on 5/5/2005. (kkc, )
April 25, 2005 Filing 5 ENDORSED LETTER (this document relates to 05cv3160) addressed to Magistrate Judge James C. Francis from Brooks R. Bruneau dated 4/14/2005; granting counsel's application for an extension of time for Ranbaxy Inc. and Ranbaxy Pharmaceuticals Inc. to file and serve its answer on 4/29/2005. (Signed by Magistrate Judge James C. Francis on 4/25/2005) Filed In Associated Cases: 1:05-md-01661-HB-JCF,1:05-cv-03160-HB(kkc, )
April 25, 2005 Opinion or Order Filing 4 MEMORANDUM AND ORDER (this document relates to 04cv6045, 05cv2234, 05cv2235); that for the reasons set forth in this Order, Novartis' motion to amend their complaints is granted. (Signed by Magistrate Judge James C. Francis on 4/25/2005) Copies Mailed by Chambers. Filed In Associated Cases: 1:05-md-01661-HB,1:04-cv-06045-HB, 1:05-cv-2234-HB, 1:05-cv-2235-HB(kkc, )
March 21, 2005 Filing 3 MOTION (FILED ON SERVICE DATE) for Issuance of Letters Rogatory directed to the appropriate authority in Tarael requesting the examination and the production of document and things of Marta Rosin-Weinstock, Zeev Tashma and representatives, employees and/or agents of Yissum Research Development Company of the Hebrew University and Hebrew University as a witness on oral examination. This document relates to 04cv6045, 05cv2234, 05cv2235. Document filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Sun Pharmaceutical Industries Ltd., Watson Pharmaceuticals Inc., Watson Laboratories Inc. (kkc, )
March 11, 2005 Opinion or Order Filing 2 ORDER REFERRING CASE TO MAGISTRATE JUDGE. Order that case be referred to the Clerk of Court for assignment to a Magistrate Judge for General Pretrial (including scheduling, discovery, non-dispositive pretrial motions, and settlement). Referred to Magistrate Judge James C. Francis. (Signed by Judge Harold Baer on 3/11/2005) (kkc, )
February 18, 2005 Filing 1 CERTIFIED TRUE COPY OF CONDITIONAL MDL TRANSFER IN ORDER FROM THE MDL PANEL... that pursuant to 28 U.S.C. 1407, the actions listed on the attached schedule A and pending in the Central District of California, Northern District of Illinois, Southern District of New York, and the same hereby are, transferred to the Southern District of New York, with the consent of that court, assigned to the Honorable Judge Harold Baer, Jr., for coordinated or consolidated pretrial proceedings with the actions pending in those districts and listed on Schedule A. (Signed by MDL Panel on 2/16/2005) (kkc, )
February 18, 2005 Magistrate Judge James C. Francis is so designated. (kkc, )
February 18, 2005 CASES ORIGINATING FROM THE SOUTHERN DISTRICT OF NEW YORK: 1:04-cv-6045 (RMB). (kkc, )

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System

Search for this case: In Re: Rivastigmine Patent Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis Pharmaceuticals Corporation
Represented By: Christopher Michael Welling
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis AG
Represented By: Christopher Michael Welling
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis Pharma AG
Represented By: Christopher Michael Welling
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis International Pharmaceutical Ltd.
Represented By: Christopher Michael Welling
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Proterra AG
Represented By: Gregory B. Sephton
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Dr. Reddy's Laboratories, Ltd.
Represented By: Maurice Newmark Ross
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Dr. Reddy's Laboratories, Inc.
Represented By: Maurice Newmark Ross
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Sun Pharmaceutical Industries Ltd.
Represented By: Derek John Sarafa
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Watson Pharmaceuticals Inc.
Represented By: Barry S. White
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Watson Laboratories Inc.
Represented By: Barry S. White
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ranbaxy Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ranbaxy Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ranbaxy Laboratories Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: Dr. Reddy's Laboratories, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: Dr. Reddy's Laboratories, Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Novartis AG
Represented By: Filko Prugo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Novartis Pharma AG
Represented By: Filko Prugo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Novartis International Pharmaceutical Ltd.
Represented By: Filko Prugo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Proterra AG
Represented By: Filko Prugo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Novartis Pharmaceuticals Corporation
Represented By: Filko Prugo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?